Business Description
Bioasis Technologies Inc
NAICS : 325412
SIC : 3741
ISIN : CA09064N1033
Compare
Compare
Traded in other countries / regions
107.GermanyBIOAF.USABTI.Canada IPO Date
2009-04-15Description
Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.32 | |||||
| 9-Day RSI | 31.47 | |||||
| 14-Day RSI | 38.42 | |||||
| 6-1 Month Momentum % | -9.43 | |||||
| 12-1 Month Momentum % | -50.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -733.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.72 | |||||
| EV-to-EBITDA | -0.74 | |||||
| EV-to-Revenue | 8.8 | |||||
| Earnings Yield (Greenblatt) % | -138.89 | |||||
| FCF Yield % | -514.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIOAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioasis Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.204 | ||
| EPS (TTM) ($) | -0.025 | ||
| Beta | 0.8 | ||
| Volatility % | 180.4 | ||
| 14-Day RSI | 38.42 | ||
| 14-Day ATR ($) | 0.000804 | ||
| 20-Day SMA ($) | 0.006258 | ||
| 12-1 Month Momentum % | -50.52 | ||
| 52-Week Range ($) | 0.0015 - 0.0182 | ||
| Shares Outstanding (Mil) | 79.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioasis Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioasis Technologies Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioasis Technologies Inc Frequently Asked Questions
What is Bioasis Technologies Inc(BIOAF)'s stock price today?
The current price of BIOAF is $0.00. The 52 week high of BIOAF is $0.02 and 52 week low is $0.00.
When is next earnings date of Bioasis Technologies Inc(BIOAF)?
The next earnings date of Bioasis Technologies Inc(BIOAF) is .
Does Bioasis Technologies Inc(BIOAF) pay dividends? If so, how much?
Bioasis Technologies Inc(BIOAF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers